BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24052155)

  • 1. Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome.
    El-Hadidi H; Samir N; Shaker OG; Otb S
    Arch Dermatol Res; 2014 Apr; 306(3):239-45. PubMed ID: 24052155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI.
    Romaní J; Caixàs A; Ceperuelo-Mallafré V; Carrascosa JM; Ribera M; Rigla M; Vendrell J; Luelmo J
    Arch Dermatol Res; 2013 Mar; 305(2):105-12. PubMed ID: 23242471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA.
    Stejskal D; Karpísek M; Humenanska V; Hanulova Z; Stejskal P; Kusnierova P; Petzel M
    Horm Metab Res; 2008 Jun; 40(6):381-5. PubMed ID: 18393169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipocalin-2 levels are increased in patients with psoriasis.
    Kamata M; Tada Y; Tatsuta A; Kawashima T; Shibata S; Mitsui H; Asano Y; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
    Clin Exp Dermatol; 2012 Apr; 37(3):296-9. PubMed ID: 22300286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of serum lipocalin-2 and retinol binding protein-4 levels in patients with psoriasis and Behçet's disease.
    Gul FC; Cicek D; Kaman D; Demir B; Nazik H
    Eur J Dermatol; 2015 Apr; 25(2):195-7. PubMed ID: 25547333
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease.
    Takahashi H; Iinuma S; Honma M; Iizuka H
    J Dermatol; 2014 Nov; 41(11):981-5. PubMed ID: 25291969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men.
    Wallenius V; Elias E; Bergstrom GM; Zetterberg H; Behre CJ
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):75-80. PubMed ID: 21104585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of serum apelin and lipocalin-2 levels in patients with subclinical hypothyroidism.
    Zorlu M; Kiskac M; Karatoprak C; Kesgin S; Cakirca M; Yildiz K; Ardic C; Cikrikcioglu MA; Erkoc R
    Ann Endocrinol (Paris); 2014 Feb; 75(1):10-4. PubMed ID: 24582591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum irisin levels in patients with psoriasis.
    Baran A; Myśliwiec H; Kiluk P; Świderska M; Flisiak I
    J Dermatolog Treat; 2017 Jun; 28(4):304-308. PubMed ID: 27786588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes.
    Kim SH; Lee SH; Ahn KY; Lee DH; Suh YJ; Cho SG; Choi YJ; Lee DH; Lee SY; Hong SB; Kim YS; Jeon JY; Nam M
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):825-33. PubMed ID: 23682797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.
    Wang Y; Lam KS; Kraegen EW; Sweeney G; Zhang J; Tso AW; Chow WS; Wat NM; Xu JY; Hoo RL; Xu A
    Clin Chem; 2007 Jan; 53(1):34-41. PubMed ID: 17040956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study.
    Liu X; Hamnvik OP; Petrou M; Gong H; Chamberland JP; Christophi CA; Kales SN; Christiani DC; Mantzoros CS
    Eur J Endocrinol; 2011 Nov; 165(5):805-12. PubMed ID: 21885675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.
    Park CG; Choi KM
    Clin Exp Hypertens; 2014; 36(7):478-83. PubMed ID: 24491219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of the adipokine lipocalin-2 are increased in preeclampsia.
    Stepan H; Philipp A; Reiche M; Klostermann K; Schrey S; Reisenbüchler C; Lossner U; Kratzsch J; Bluher M; Stumvoll M; Fasshauer M
    J Endocrinol Invest; 2010 Oct; 33(9):629-32. PubMed ID: 20208456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.
    Baran A; Świderska M; Myśliwiec H; Flisiak I
    J Dermatolog Treat; 2017 Mar; 28(2):136-140. PubMed ID: 27165470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epicardial adipose tissue thickness and NGAL levels in women with polycystic ovary syndrome.
    Sahin SB; Cure MC; Ugurlu Y; Ergul E; Gur EU; Alyildiz N; Bostan M
    J Ovarian Res; 2014 Feb; 7():24. PubMed ID: 24528623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease.
    Choi KM; Lee JS; Kim EJ; Baik SH; Seo HS; Choi DS; Oh DJ; Park CG
    Eur J Endocrinol; 2008 Feb; 158(2):203-7. PubMed ID: 18230827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and other cardiovascular risk factors in patients with lichen planus.
    Saleh N; Samir N; Megahed H; Farid E
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1507-13. PubMed ID: 24330130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.
    Ataseven A; Kesli R; Kurtipek GS; Ozturk P
    Dis Markers; 2014; 2014():541709. PubMed ID: 24803721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.